




Searching News Database: neurogenic orthostatic hypotension
HSMN NewsFeed - 7 Mar 2017
Milestone Pharmaceuticals Announces Appointment of Joseph G. Oliveto as Chief Executive Officer
Milestone Pharmaceuticals Announces Appointment of Joseph G. Oliveto as Chief Executive Officer
HSMN NewsFeed - 27 Jan 2014
Chelsea Therapeutics Announces Joseph G. Oliveto Named President and Chief Executive Officer, Director
Chelsea Therapeutics Announces Joseph G. Oliveto Named President and Chief Executive Officer, Director
HSMN NewsFeed - 30 Jun 2008
William D. Schwieterman, M.D. Joins Chelsea Therapeutics' Board of Directors
William D. Schwieterman, M.D. Joins Chelsea Therapeutics' Board of Directors
HSMN NewsFeed - 12 Nov 2007
FDA Accepts Chelsea Therapeutics' Investigational New Drug Application for Droxidopa
FDA Accepts Chelsea Therapeutics' Investigational New Drug Application for Droxidopa
HSMN NewsFeed - 14 Aug 2007
European Commission Grants Chelsea Therapeutics Two Orphan Medicinal Product Designations for Droxidopa
European Commission Grants Chelsea Therapeutics Two Orphan Medicinal Product Designations for Droxidopa